Credits: Canva
The clothes you wear when you work out may do you more harm than helping you to stay healthy as you hit the gym. This is because research has revealed alarming levels of bisphenol A (BPA), a chemical compound linked to significant health risks in several sports wear, including sports bra, leggings, and athletic wear. The Center for Environmental Health (CEH), which is a nonprofit consumer advocacy group has brought these concerns to light, and have raised awareness about the potential danger and damage these sports wear can cause because of the common chemicals used.
Bisphenol A, or BPA is a chemical that is used to make plastics and resins. It is also used in certain fabrics and is known for its endocrine-disrupting properties, which can also interfere with one's hormonal balance. There have been studies, including a 2019 study titled The adverse health effects of bisphenol A and related toxicity mechanisms that have linked BPA exposure to various health problems, including asthma, cardiovascular diseases, obesity, diabetes, and even cancer.
Many of research which have been conducted focus on the ingestion, which can happen when you store food in BPA-lined containers. Among them, some of the more recent studies show that skin absorption is also a pathway. This means when you are handling receipts which are printed on thermal paper, or wear BPA-containing fabrics, the chemical can seep through your skin and enter your bloodstream.
Though it is also true that BPA is exposed from the body within days, however, continuous exposure from multiple sources can be concerning.
CEH also tested popular athletic wear in October 2023 and found BPA levels were exceeding California's safety standards by as much as 22 times.
Testing also showed that top brands contained up to 40 times the permissible limit of BPA.
As far as laws are concerned, under California's Proposition 65, the maximum allowable dose for BPA exposure via skin is 3 micrograms per day. While this law is among the strictest in the United States, it highlights a broader issue of chemical safety in consumer products nationwide.
Ana Soto, an immunologist with decades of research on BPA, even low doses of dermal and oral exposure can combine to create a significant health risk. She also warned that prolonged exposure through fabric, especially when you are exercising, as your pores are open and sweat is present, can in fact, amplify these effects.
BPA can disrupt your body's endocrine system, which is a network of glands and organs that produce hormones that control many bodily functions. These include growth and development, metabolism, and reproduction, to name a few. BPA can mimic natural hormones like estrogen and interfere in those bodily functions.
Studies also link it with obesity and diabetes, respiratory issues, especially asthma risk in school-aged children, cardiovascular diseases, and cancer risks.
There are certain steps you can follow to protect yourself:
Credit: AI
Breast cancer is generally considered to be a problem of old age. In India, however, breast cancer is usually diagnosed in women who are in their 40s and 50s, a decade before the average age group in several other parts of the world. While this difference has clinical significance, the reasons behind it are varied and cannot be pinned down to any one biological or genetic cause.
Age, hormones, heredity, reproductive history and environment play roles in determining the risk of breast cancer. Historically, differences in age at first birth, number of pregnancies and breastfeeding period could have been responsible for the variance seen in risk levels across populations. Presently, the changing pattern of reproduction, late age of first pregnancy, lower number of births and less breastfeeding among certain groups of Indians could affect the risk of breast cancer.
Other changes include dietary, physical activity and body weight trends due to urbanization. Being overweight, especially postmenopausal, and excessive alcohol intake are known risk factors for breast cancer. But this alone does not account for the difference in age profile of breast cancer in India.
Genetic susceptibility is another factor which needs to be taken into account. Mutations in the inherited genes, including BRCA1 and BRCA2, may lead to the increased risk of development of breast cancer in young women. Nonetheless, there is no sufficient information to suggest that a particular genetic background specific for the Indian population contributes to this difference. More research in the field of genomics is needed.
Another thing to take into account is that the young age of the patients does not mean that the breast cancer occurs more frequently in India compared to other countries. Higher age-standardized incidence rates have been observed in Western countries due to reproductive behaviors, lifestyles, and screenings. Younger age of Indian patients may also be explained by demographic factors, as well as the difference in screenings and diagnoses.
Also read: Breast Cancer: Know the Risks, Recognise the Signs & Get Checked
Indian cancer centers report significant shares of hormone receptor-negative, HER2-positive, and triple-negative breast cancers, as well as a more advanced stage of the disease at the time of diagnosis. Aggressive biological types among these subgroups might require aggressive therapy.
Nonetheless, it is critical not to generalize this information and apply it to all Indian women and breast cancers developed at a younger age. It may be questioned whether hospital-based studies reflect the whole population, as there is variation in tumour subtypes within the population.
Late diagnosis is one of the main problems. Poor awareness, fear and stigma, family obligations, financial constraints and delayed health-care visitation result in growth and spread of tumours before starting treatment. Young women may ignore a breast lump because they think that being young prevents them from developing breast cancer. It may be dangerous.
The issue requires clarification between awareness, diagnosis and screening.
Breast awareness should start in early adulthood. Women should be aware of their normal breast condition and have an immediate medical check up if they find any changes such as a breast lump, nipple retraction, bleeding nipple discharge, skin dimpling and others, regardless of age. Suspicious change requires diagnosis rather than waiting until next screening examination.
In asymptomatic women, it is necessary to determine the ideal age and screening method according to Indian conditions. Mammography is well-known screening tool, ultrasound could assist in evaluating dense breast tissue in younger women. Both should not be over-used without proper medical evaluation. Women who have a robust family history or those carrying high-risk genes should have an earlier and more rigorous surveillance program.
What India requires is a systematic and risk-appropriate early detection program that includes public awareness, medical evaluation, screening, and treatment.
The bottom line is that breast cancer does not occur only among older patients. Early detection of symptoms and changes can make a difference in saving lives.
By Dr Sewanti Limaye, Director of Medical & Precision Oncology, Sir H. N. Reliance Foundation Hospital, Mumbai
Credit: iStock
Menopause typically occurs between the ages of 45 and 55. However, the hormonal changes leading up to it can begin earlier, with some women reporting symptoms in their 30s.
A 2025 study published in NPJ Women's Health examined 4,400 American women aged 30 and older. It found that roughly 55% of women aged 30-35 reported moderate or severe symptoms on the Menopause Rating Scale. The proportion rose to just over 64% among women aged 36-40. Despite these symptoms, most women did not seek treatment until they were 56 or older.
Speaking to HealthandMe, Dr. Kajal Parikh is an Obstetrician and a Gynecologist based in Mumbai, explained how hormonal changes can begin in the mid-to-late 30s, the signs women should watch for, and why monitoring symptoms and maintaining healthy habits matter during this transition.
From the first menstrual period to menopause, the body undergoes significant hormonal changes. Estrogen and progesterone are among the hormones involved in this process.
“These hormones don't exit overnight. The exit starts much earlier. Starting mid-30s to late 30s, the hormone levels start depleting. Now, when that level starts depleting, you're going to see signals.”
According to Dr Parikh, changes in menstrual cycles can be among the first signs. Periods may become heavier or lighter, while cycles may become shorter or longer.
Being mindful of these changes can help women identify patterns and discuss persistent or concerning symptoms with a healthcare professional. However, these symptoms alone do not confirm that a woman is in perimenopause.
Also read: Menopause Abruptly Shifts Bones, Liver And Blood Fats, Study Finds
Perimenopause symptoms can extend beyond menstrual changes. Women may notice dry skin, pigmentation, hair thinning, increased hair fall, low energy, brain fog and disturbed sleep.
Some women who previously slept well may begin waking up at 3 or 4 a.m. and find it difficult to return to sleep, Dr Parikh told HealthandMe.
“That's your body asking for some help, or rather the body signaling that we are going through some crisis, see how we can fix it.”
Other possible symptoms include breast tenderness, worsening premenstrual symptoms, headaches, migraines, and bone and joint pain. Vaginal dryness, changes in urinary habits and reduced libido may also occur.
Symptoms vary considerably between individuals, and many of these changes can have causes other than perimenopause, the expert said,
Read More: ‘I Was Vocal About Cancer But Silent About Menopause Out Of Shame’, Says Actress Lisa Ray
Dr Parikh recommended annual gynecological visits to monitor changes over time. She also advised women to track their symptoms and seek medical advice if they worsen or do not improve with treatment.
Although menstrual changes may become noticeable in the late 30s and early 40s, the timing of the menopausal transition varies. Some women experience menopause earlier than expected, while others continue menstruating into their 50s.
For women without symptoms, Dr Parikh identified 40 as an appropriate age to begin regular monitoring and annual screening.
“40 is that golden age when you start monitoring, when you start getting your annual screenings done.”
The need for specific tests depends on a woman's age, symptoms and medical history. Women experiencing menstrual changes or possible menopausal symptoms at a younger age should consult a healthcare professional rather than waiting until 40.
Dr Parikh said doctors may assess iron levels, thyroid function, blood sugar and lipid levels while reviewing a woman's diet, nutrition and exercise habits. These assessments can help identify other conditions that may contribute to symptoms.
She also emphasised the importance of sleep, nutrition and exercise during the menopausal transition.
“The only thing that will save you from this transition are your three strong pillars, which is your sleep, your nutrition, and your exercise regimen.”
Treatment depends on the symptoms and individual health needs. After assessing symptoms and ruling out other possible causes, doctors can discuss appropriate options, including hormone therapy when indicated.
READ: Can Menopause Be Delayed? What Science Says About Slowing Ovarian Aging
Dr Parikh said genetics can play a role in determining when menopause occurs. A family history of early menopause, including in a woman's mother or grandmother, may be relevant when discussing her own reproductive health.
She also raised concerns about potential environmental exposures, including endocrine-disrupting chemicals found in some products and packaging. However, their individual contribution to the timing of menopause is difficult to establish, and these exposures should not be presented as proven causes of early menopause.
Maintaining a balanced diet, exercising regularly and prioritising sleep can support overall health during the menopausal transition.
Credit: iStock
For a patient with advanced heart failure, there comes a point when medicines, devices and repeated hospitalisations can no longer control the disease. For some, a heart transplant may offer the only realistic path to long-term survival. Yet in India, the challenge often begins much earlier than the waiting list: many patients who could potentially benefit from transplantation never reach an advanced heart-failure or transplant centre for evaluation.
The scale of the problem is enormous. A recent study found that 83,000 heart transplantations were required annually in India in 2021, although only a very small proportion of that need was met. In comparison, according to the National Organ and Tissue Transplant Organisation (NOTTO), 221 heart transplants were performed in 2023.
The first issue is delayed referral. Patients with advanced heart failure may continue to be treated repeatedly for breathlessness, fluid retention or hospital admissions without being assessed early for advanced therapies.
A transplant evaluation is not a last-minute decision. It requires time to assess the patient's medical condition, other organs, infection risk, nutrition, psychosocial circumstances and ability to undergo lifelong follow-up.
The second challenge is the limited availability of donor hearts. Heart transplantation depends almost entirely on deceased organ donation. India has made substantial progress in transplantation overall, but the national deceased organ donation rate remains less than one donor per million population.
Geography and affordability also matter. Advanced heart-failure programmes and transplant centres are concentrated in selected regions, meaning that patients from smaller cities and rural areas may face substantial travel, financial and logistical barriers.
The cost of evaluation, repeated hospitalisations, mechanical circulatory support and post-transplant medicines can further influence whether a patient can realistically pursue transplantation.
We therefore need to change the way advanced heart failure is recognised. A patient with recurrent hospitalisations, persistent symptoms despite optimal therapy, progressive kidney or liver dysfunction, low blood pressure limiting medications, or dependence on intravenous therapies should trigger consideration of referral to an advanced heart-failure centre.
Early referral gives specialists more time to evaluate the patient, assess treatment options and determine whether transplantation or another advanced therapy is appropriate.
Importantly, transplantation is not the only advanced therapy. Left ventricular assist devices (LVADs) can serve as a bridge to transplantation or, in selected patients, as long-term therapy.
These devices can help support the heart's pumping function in patients with advanced heart failure who meet the criteria for their use. The appropriate option depends on the patient's condition, overall health and treatment goals.
India has demonstrated that transplantation can grow rapidly when infrastructure, coordination and public awareness improve. The next step is to ensure that patients are identified early enough to be evaluated, and that a shortage of donor organs does not remain the only reason they never get the opportunity to reach the transplant list.
By Dr. Pravin Kulkarni, MBBS, MS (General Surgery), MCh (Cardiovascular and Thoracic Surgery), Fellowship in CTS, Director, Advanced Cardiac Surgery and Heart and Lung Transplant Program
© $2026 Times Horizon Private Limited